Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Mitochondrially encoded tRNA-Proline (MT-TP, also known as trnP or tRNA^Pro) is a small non-coding RNA encoded by the mitochondrial genome that functions as a transfer RNA for proline during mitochondrial protein synthesis[4][5]. Like all mitochondrial tRNAs, MT-TP is critical for the translation of mRNAs that encode subunits of the oxidative phosphorylation complexes in human mitochondria, which are essential for cellular energy production. The mitochondrial tRNAs exhibit unique structural characteristics compared to nuclear-encoded tRNAs, and their proper maturation—including processing, modification (such as methylation), and 3′-CCA tail addition—is vital for their function[1][3]. Mutations in MT-TP can disrupt mitochondrial translation and have been implicated in some mitochondrial disorders[4]. MT-TP is not considered a conventional druggable target, receptor, enzyme, or transporter; rather, it serves a fundamental role as an adapter molecule in protein biosynthesis within mitochondria.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Mitochondrially encoded tRNA-Proline (MT-TP).